143 related articles for article (PubMed ID: 3503595)
1. Nifedipine gastrointestinal therapeutic system.
Swanson DR; Barclay BL; Wong PS; Theeuwes F
Am J Med; 1987 Dec; 83(6B):3-9. PubMed ID: 3503595
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
Chung M; Reitberg DP; Gaffney M; Singleton W
Am J Med; 1987 Dec; 83(6B):10-4. PubMed ID: 3503594
[TBL] [Abstract][Full Text] [Related]
3. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
Grundy JS; Foster RT
Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
[TBL] [Abstract][Full Text] [Related]
4. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
[TBL] [Abstract][Full Text] [Related]
5. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
[TBL] [Abstract][Full Text] [Related]
6. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
[TBL] [Abstract][Full Text] [Related]
7. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine.
Vetrovec GW; Parker VE; Cole S; Procacci PM; Tabatznik B; Terry R
Am J Med; 1987 Dec; 83(6B):24-9. PubMed ID: 3140660
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.
Chung M; Vashi V; Puente J; Sweeney M; Meredith P
Br J Clin Pharmacol; 1999 Nov; 48(5):678-87. PubMed ID: 10594469
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis--tolerance and pharmacokinetic profile.
Juon AM; Kühn-Velten WN; Burkhardt T; Krähenmann F; Zimmermann R; von Mandach U
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):27-32. PubMed ID: 18394772
[TBL] [Abstract][Full Text] [Related]
11. Sandwiched osmotic tablet core for nifedipine controlled delivery.
Liu L; Khang G; Rhee JM; Lee HB
Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of monolithic osmotic tablet system for nifedipine delivery in vitro and in vivo.
Liu X; Chen D; Zhang R
Drug Dev Ind Pharm; 2003 Aug; 29(7):813-9. PubMed ID: 12906339
[TBL] [Abstract][Full Text] [Related]
13. Controlling drug effects through improved oral formulations. The pharmacokinetics of the prazosin gastrointestinal therapeutic system.
DiPiro JT
Am J Med; 1989 Aug; 87(2A):31S-35S. PubMed ID: 2764016
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of nifedipine absorption from GITS tablets: comparison of single-dose pharmacokinetics using 10, 20, 40 and 60 mg nifedipine.
Tateishi T; Okumura K; Orii Y; Tanaka T
Int J Clin Pharmacol Ther; 2004 Jan; 42(1):58-62. PubMed ID: 14756389
[TBL] [Abstract][Full Text] [Related]
15. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
[TBL] [Abstract][Full Text] [Related]
16. Monolithic osmotic tablet system for nifedipine delivery.
Liu L; Khang G; Rhee JM; Lee HB
J Control Release; 2000 Jul; 67(2-3):309-22. PubMed ID: 10825563
[TBL] [Abstract][Full Text] [Related]
17. [Unitary-core osmotic pump tablet for controlled release of water-insoluble drug].
Liu LX; Xu Q; Khang G; Rhee JM; Lee HB
Yao Xue Xue Bao; 2003 Dec; 38(12):966-7. PubMed ID: 15040097
[TBL] [Abstract][Full Text] [Related]
18. A squeeze-type osmotic tablet for controlled delivery of nifedipine.
Park JS; Shin JH; Lee DH; Kim MS; Rhee JM; Lee HB; Khang G
J Biomater Sci Polym Ed; 2008; 19(1):31-45. PubMed ID: 18177552
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system.
Bittar N
Am J Cardiol; 1989 Sep; 64(11):31F-34F. PubMed ID: 2675587
[TBL] [Abstract][Full Text] [Related]
20. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Cardiol; 1989 Sep; 64(11):65F-69F. PubMed ID: 2782273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
